Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology | Genetic Disease
Hereditary Angioedema Clinical Trials
A listing of Hereditary Angioedema medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Scottsdale : United States, Arizona
Patient Registry Study of Berinert® in Normal Clinical Practice
California
Granada Hills : United States, California
Patient Registry Study of Berinert® in Normal Clinical Practice
Los Angeles : United States, California
Patient Registry Study of Berinert® in Normal Clinical Practice
Colorado
Colorado Springs : Associate, Asthma & Allergy Associates, P.C.
Cinryze for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12
Florida
Tampa : University of South Florida
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Georgia
Atlanta : United States, Georgia
Patient Registry Study of Berinert® in Normal Clinical Practice
Idaho
Idaho Falls : United States, Idaho
Patient Registry Study of Berinert® in Normal Clinical Practice
Louisiana
New Orleans : United States, Louisiana
Patient Registry Study of Berinert® in Normal Clinical Practice
Maryland
Chevy Chase : Institute for Asthma and Allergy, PC
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Chevy Chase : United States, Maryland
Patient Registry Study of Berinert® in Normal Clinical Practice
Columbia : United States, Maryland
Patient Registry Study of Berinert® in Normal Clinical Practice
Wheaton : Institute for Allergy and Asthma Updated
Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema
Massachusetts
Boston : Boston Children's Hospital
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Minnesota
Plymouth : United States, Minnesota
Patient Registry Study of Berinert® in Normal Clinical Practice
Missouri
Kansas City : United States, Missouri
Patient Registry Study of Berinert® in Normal Clinical Practice
St. Louis : United States, Missouri
Patient Registry Study of Berinert® in Normal Clinical Practice
New Jersey
Branchburg : United States, New Jersey
Patient Registry Study of Berinert® in Normal Clinical Practice
Edison : United States, New Jersey
Patient Registry Study of Berinert® in Normal Clinical Practice
Iselin : United States, New Jersey
Patient Registry Study of Berinert® in Normal Clinical Practice
Ocean : United States, New Jersey
Patient Registry Study of Berinert® in Normal Clinical Practice
New York
Mineola : Winthrop University Hospital Clinical Trials Center
HAE - Patients diagnosed with Acute Hereditary Angioedema
View More »
New York : United States, New York
Patient Registry Study of Berinert® in Normal Clinical Practice
North Carolina
Durham : United States, North Carolina
Patient Registry Study of Berinert® in Normal Clinical Practice
Ohio
Centerville : United States, Ohio
Patient Registry Study of Berinert® in Normal Clinical Practice
Cincinnati : United States, Ohio
Patient Registry Study of Berinert® in Normal Clinical Practice
Oklahoma
Oklahoma City : United States, Oklahoma
Patient Registry Study of Berinert® in Normal Clinical Practice
Tulsa : United States, Oklahoma
Patient Registry Study of Berinert® in Normal Clinical Practice
Oregon
Lake Oswego : Allergy, Asthma and Dermatoligy Research Center, LLC
Cinryze for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12
Lake Oswego : United States, Oregon
Patient Registry Study of Berinert® in Normal Clinical Practice
Pennsylvania
Altoona : United States, Pennsylvania
Patient Registry Study of Berinert® in Normal Clinical Practice
Hershey : Penn State University
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Hershey : United States, Hershey
Patient Registry Study of Berinert® in Normal Clinical Practice
Pittsburgh : United States, Pennsylvania
Patient Registry Study of Berinert® in Normal Clinical Practice
South Carolina
Columbia : United States, South Carolina
Patient Registry Study of Berinert® in Normal Clinical Practice
South Dakota
Rapid City : United States, South Dakota
Patient Registry Study of Berinert® in Normal Clinical Practice
Texas
Dallas : AARA Research Center
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Dallas : AARA Research Center Updated
Efficacy, Safety and Tolerability of a Self-Administered Subcutaneous Formulation of Icatibant for the Treatment of Acute Attacks of Hereditary Angioedema
Dallas : United States, Texas
Patient Registry Study of Berinert® in Normal Clinical Practice
Washington
Spokane : Marycliff Allergy Specialists
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Spokane : United States, Washington
Patient Registry Study of Berinert® in Normal Clinical Practice
Tacoma : United States, Washington
Patient Registry Study of Berinert® in Normal Clinical Practice
Austria
Graz : University of Graz
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Canada
Hamilton : McMaster University
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Denmark
Odense : Odense Hospital
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Odense C : Denmark, Odense C
Patient Registry Study of Berinert® in Normal Clinical Practice
France
Angers : ViroPharma Investigational Site Updated
A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
Angers Cedex 10 : CHU Angers
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Bondy : Hôpital Jean Verdier
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Bordeaux : Hôpital Pellegrin
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Caen : CHU Hôpital de la Cote de Nacre
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
View More »
Grenoble : CHU de Grenoble
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Le Mans : Hôpital du Mans
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Lille : Hôpital Claude Huriez
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Lyon Cedex 3 : CHRU Hôpital Edourad Herriot
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Nancy : ViroPharma Investigational Site Updated
A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
Nancy : Hôpital Central
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Nantes : CHU Hotel Dieu
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Nice : CHU Hôpital l'Archet 1
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Niort : CH Niort
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Paris : ViroPharma Investigational Site Updated
A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
Paris Cedex 4 : CHU Hotel Dieu
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
St. Etienne : CHU St. Etienne
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Strasbourg : CHU Hôpital de Hautepierre
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Toulouse : CHU Purpan Toulouse
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Germany
Berlin : ViroPharma Investigational Site Updated
A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
Berlin : ViroPharma Investigational Site
Cinryze for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12
Berlin : Charite Universitatsmedizin Berlin
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Berlin : Germany, Berlin
Patient Registry Study of Berinert® in Normal Clinical Practice
Berlin : Charité Hospital
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
View More »
Dresden : Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Essen : ViroPharma Investigational Site Updated
A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
Essen : Klinik und Poliklinik fur Hals Nasen Ohrenheilkunde
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Frankfurt : ViroPharma Investigational Site Updated
A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
Frankfurt : Klinikum der Johann Wolfgang Goethe University
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Frankfurt : Germany, Frankfurt
Patient Registry Study of Berinert® in Normal Clinical Practice
Frankfurt : University Hospital Frankfurt
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Mainz : ViroPharma Investigational Site Updated
A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
Mainz : Johannes-Gutenberg University Clinical Research Center
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Mainz : Universitatshautklinik Mainz
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
München : Klinikum rechts der Isar, Hals-Nasen-Ohrenklinik TUM
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Munich : ViroPharma Investigational Site Updated
A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
Munich : ViroPharma Investigational Site
Cinryze for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12
Munich : Klinikum Rechts der Isar, Technical University Munich
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Greece
Athens : Naval Hospital of Athens
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Hungary
Budapest : Heim Pal Childrens Hospital
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Budapest : ViroPharma Investigational Site
Cinryze for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12
Ireland
Dublin : Beaumont Hospital
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Israel
Haifa : Bnai Zion Medical Center, Allergy and Immunology Institute
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Haifa : Bnai Medical Center
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Haifa : Bnei Zion Hospital
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Tel Aviv : Tel Aviv Sourasky Medical Center, Pulmonology and Allergy Unit
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Tel Hashomer : Sheba Medical Center Allergy and Immunology Angioedema Center
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
View More »
Tel Hashomer : Sheba Medical Center
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Tel-Aviv : Souraski Medical Center
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Italy
Bari : Policlinico
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Milan : Hospital Luigi Sacco
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Milano : Unita Operativa Medicina II Ospedale Luigi Sacco
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Naples : University of Naples Federico II, Dipartimento di Medicina Interna
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Napoli : Universtia degli Studi di Napoli Federico II
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
View More »
Padova : Università degli Studi di Padova
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Palermo : U.O.C. di Patologia Clinica, Ospedale Cervello
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Netherlands
Poland
Krakow : Pediatric Hospital
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Lublin : Pediatric Hospital
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Romania
Targu Mures : Mures County Clinical Hospital
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Spain
Alicante : Hospital Marina Baixa Vila Joiosa
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Barcelona : Hospital Vall DHebron
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Gijon : Hospital de la Cruz Roja
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
L'Hospitalet de Llobregat : Hospital Bellvitge
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Lleida : Hospital Santa Maria
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
View More »
Logrono : Hospital San Pedro
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Madrid : Hospital Universitario Gregorio Maranon
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Madrid : Hospital Universtiario La Paz
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Valencia : ViroPharma Investigational Site Updated
A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
Valencia : University Hospital, Pediatric Pulmonology and Allergy Unit
A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Valencia : Hospital La Fe
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Sweden
Jonkoping : Länssjukhuset Ryhov
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Switzerland
Luzern 16 : Switzerland, Luzern 16
Patient Registry Study of Berinert® in Normal Clinical Practice
United Kingdom
Bristol : Southmeand Hospital
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
London : ViroPharma Investigational Site Updated
A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
London : Royal London
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Manchester : Manchester Royal Infirmary
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
Newcastle upon Tyne : Royal Victoria Infirmary
Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS)
